Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Targu – page 2

26 clinical trials in Targu, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Targu at a glance
26
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

26 trials in Targu

Open in trial search

Psoriatic arthropathy

Not recruiting

Study on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Systemic scleroderma

Not recruiting

Study on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:BI 685509
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Atrial fibrillation

Not recruiting

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational
Countries:RomaniaRomania
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Litifilimab
  • Sponsor:Biogen Idec Research Limited

Study on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Sotagliflozin
  • Sponsor:Lexicon Pharmaceuticals Inc.

Study on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:JTT-861 monohydrochloride dihydrate
  • Sponsor:Akros Pharma Inc.

Dry eye+1

Not recruiting

Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ianalumab
  • Sponsor:Novartis Pharma AG

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Study on the Effectiveness and Safety of Afimetoran for Patients with Active Lupus

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Afimetoran Besilate Dihydrate
  • Sponsor:Beeline Medicines Corp.

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Targu

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking clinical trials focusing on heart failure prevention and treatment of hypertrophic cardiomyopathy. Studies evaluating innovative combination therapies and novel compounds for cardiac conditions.

  • Heart Failure Prevention
  • Cardiomyopathy Treatment
  • Stroke Prevention

Research includes assessment of new therapeutic approaches for managing cardiovascular complications and improving patient outcomes.

02 Hematology & Oncology

Advanced research in blood disorders and cancer treatments, including studies on lymphoma and leukemia. Innovative therapies being evaluated for rare conditions like paroxysmal nocturnal hemoglobinuria.

  • Blood Disorders
  • Lymphoma Treatment
  • Leukemia Therapy

Focus on developing targeted treatments and improving patient care in hematologic conditions.

03 Neurological Disorders

Comprehensive studies investigating treatments for epilepsy and multiple sclerosis. Research evaluating extended-release formulations and novel therapeutic approaches.

  • Seizure Management
  • Multiple Sclerosis Treatment
  • Myasthenia Gravis Therapy

Emphasis on improving quality of life and treatment outcomes for patients with neurological conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.